[go: up one dir, main page]

DE60336602D1 - Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis - Google Patents

Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis

Info

Publication number
DE60336602D1
DE60336602D1 DE60336602T DE60336602T DE60336602D1 DE 60336602 D1 DE60336602 D1 DE 60336602D1 DE 60336602 T DE60336602 T DE 60336602T DE 60336602 T DE60336602 T DE 60336602T DE 60336602 D1 DE60336602 D1 DE 60336602D1
Authority
DE
Germany
Prior art keywords
metered dose
dose inhaler
container
suspension
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336602T
Other languages
English (en)
Inventor
Saeed Chaudhry
Stefan A Sharpe
Julianne Berry
Joel A Sequeira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE60336602D1 publication Critical patent/DE60336602D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/003—Adding propellants in fluid form to aerosol containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE60336602T 2002-08-27 2003-08-26 Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis Expired - Lifetime DE60336602D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40612702P 2002-08-27 2002-08-27
US42243602P 2002-10-30 2002-10-30

Publications (1)

Publication Number Publication Date
DE60336602D1 true DE60336602D1 (de) 2011-05-12

Family

ID=31981380

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60336602T Expired - Lifetime DE60336602D1 (de) 2002-08-27 2003-08-26 Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
DE60318727T Expired - Lifetime DE60318727T2 (de) 2002-08-27 2003-08-26 Verfahren zur herstellung von dosierinhalatorformulierungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60318727T Expired - Lifetime DE60318727T2 (de) 2002-08-27 2003-08-26 Verfahren zur herstellung von dosierinhalatorformulierungen

Country Status (14)

Country Link
US (3) US20040042973A1 (de)
EP (2) EP1878664B1 (de)
JP (3) JP4679901B2 (de)
AT (2) ATE384001T1 (de)
AU (1) AU2003265639A1 (de)
CA (1) CA2495875C (de)
CY (1) CY1107376T1 (de)
DE (2) DE60336602D1 (de)
DK (1) DK1542904T3 (de)
ES (1) ES2297262T3 (de)
MX (1) MXPA05002248A (de)
PT (1) PT1542904E (de)
SI (1) SI1542904T1 (de)
WO (1) WO2004020289A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ATE353231T1 (de) * 2002-08-23 2007-02-15 Schering Corp Pharmazeutische zusammensetzungen
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
SE0401408D0 (sv) * 2004-06-02 2004-06-02 Astrazeneca Ab Diameter measuring device
EP1811981B1 (de) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP2083798A1 (de) * 2006-10-19 2009-08-05 Cipla Limited Pharmazeutische zusammensetzungen und nasenspray mit wasserfreiem mometason-furoat
AU2007346134A1 (en) 2007-02-09 2008-08-14 Merck Sharp & Dohme Corp. Stable pharmaceutical drug aerosols
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
US20120128736A1 (en) * 2009-05-12 2012-05-24 Galenica Ab Oil-in-water emulsion of mometasone
US20130112194A1 (en) * 2010-02-10 2013-05-09 Simon Christopher Berry Process for providing a filled canister for an inhaler
AU2015200276B2 (en) * 2010-02-10 2016-01-21 Astrazeneca Uk Limited A filled canister for an inhaler
CN107626019A (zh) * 2016-07-18 2018-01-26 卓效医疗有限公司 手持式喷雾器
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592319A (en) * 1968-10-28 1971-07-13 Roy S Rousseau Article feed control
US3835898A (en) * 1972-11-13 1974-09-17 Kartridg Pak Co Remotely adjustable filling head
US4793461A (en) * 1987-02-26 1988-12-27 The Kartridg Pak Co. Container feed apparatus
US5143260A (en) * 1990-06-05 1992-09-01 Nozone Dispenser Systems, Inc. Aerosol adapter clamp and power system
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
HUT67449A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
CA2111003A1 (en) * 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5275212A (en) * 1993-02-24 1994-01-04 Minnesota Mining And Manufacturing Company Aerosol filling method
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US5698161A (en) 1996-08-26 1997-12-16 Michigan Critical Care Consultants, Inc. Hollow, multi-dimensional array membrane
DK0927037T3 (da) * 1996-08-29 2001-09-24 Schering Corp Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
EP1311294A2 (de) * 2000-08-04 2003-05-21 Longwood Pharmaceutical Research, Inc. Formulierung enhaltend mometason und einen brochodilatator für pulmonaren anwendung
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ATE353231T1 (de) * 2002-08-23 2007-02-15 Schering Corp Pharmazeutische zusammensetzungen
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
EP1981545A2 (de) * 2006-02-09 2008-10-22 Schering Corporation Pharmazeutische formulierungen
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Also Published As

Publication number Publication date
CA2495875A1 (en) 2004-03-11
ATE384001T1 (de) 2008-02-15
PT1542904E (pt) 2008-03-24
JP2011046726A (ja) 2011-03-10
SI1542904T1 (sl) 2008-06-30
CY1107376T1 (el) 2012-12-19
EP1542904B1 (de) 2008-01-16
US20130068218A1 (en) 2013-03-21
US20040042973A1 (en) 2004-03-04
DK1542904T3 (da) 2008-04-21
WO2004020289A1 (en) 2004-03-11
ATE503687T1 (de) 2011-04-15
DE60318727T2 (de) 2009-01-08
MXPA05002248A (es) 2005-06-08
EP1542904A1 (de) 2005-06-22
EP1878664A1 (de) 2008-01-16
ES2297262T3 (es) 2008-05-01
EP1878664B1 (de) 2011-03-30
JP4679901B2 (ja) 2011-05-11
AU2003265639A1 (en) 2004-03-19
US20080066744A1 (en) 2008-03-20
JP2006305390A (ja) 2006-11-09
DE60318727D1 (de) 2008-03-06
CA2495875C (en) 2010-06-22
JP2005537095A (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
CY1107376T1 (el) Μεθοδος παρασκευης συνταγοποιησεων για συσκευη εισπνοης μετρημενης δοσης
FI2515855T6 (fi) Yhdistelmähoito keuhkoahtaumatautia (copd) varten
CA2353959A1 (en) A medicinal aerosol formulation
FI109875B (fi) Painekaasupakkauksia, jotka on saatu käyttämällä polyoksietyleeniglyseryylioleaatteja
UA89751C2 (ru) Состав, который содержит сульфат альбутерола и бромид ипратропия, способ его получения и ингалятор
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
RU94040361A (ru) Аэрозольная фармацевтическая композиция, баллончик для доставки композиции, дозировочный ингалятор, способ лечения респираторных заболеваний, способ получения композиции
RU2016141961A (ru) Несмываемая химическая пена, содержащая пероксид бензоила
MX336225B (es) Composiciones que comprenden sulfato de salbutamol.
ATE293957T1 (de) Verfahren zur herstellung von inhalationspulvern
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
MX2011005892A (es) Metodo y aparato para el empaque y dispensado de productos farmaceuticos.
CN101525164A (zh) 一种用于水体快速增氧、消毒的过碳酸钠制剂及其制备方法
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
EP1267796B1 (de) Schäumbare fluoridzubereitungen für zahnärztliche zwecke
CN110547977B (zh) 一种含小苏打的口腔护理组合物及其制备方法和应用
US20160220465A1 (en) Minoxidil formulations
JP6018438B2 (ja) 滴下式エアゾール製品
BRPI0607990A2 (pt) formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol
CN1385165A (zh) 利巴韦林雾化吸入溶液
CN103751814A (zh) 制备长有效期的锝[99mTc]亚甲基二膦酸盐注射液药品的方法
CN105213424A (zh) 一种甘油果糖氯化钠注射液的制备方法
JP6511375B2 (ja) 二酸化塩素ガス発生方法
CN110801461A (zh) 一种治疗湿疹的气雾剂
JP2019131414A (ja) 二酸化塩素発生エアゾール